Unbalanced risk-benefit analysis of ADHD drugs

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning

Adgang til dokumentet

@article{48fededc0d614ca98ce70135e7388183,

title = "Unbalanced risk-benefit analysis of ADHD drugs",

author = "Faltinsen, {Erlend G.} and Christian Gluud and Erik Simonsen and Morris Zwi and Storeb{\o}, {Ole Jakob}",

year = "2018",

month = nov,

doi = "10.1016/S2215-0366(18)30334-1",

language = "English",

volume = "5",

journal = "The Lancet Psychiatry",

issn = "2215-0366",

publisher = "Elsevier",

number = "11",

}

TY - JOUR

T1 - Unbalanced risk-benefit analysis of ADHD drugs

AU - Faltinsen, Erlend G.

AU - Gluud, Christian

AU - Simonsen, Erik

AU - Zwi, Morris

AU - Storebø, Ole Jakob

PY - 2018/11

Y1 - 2018/11

UR - http://www.scopus.com/inward/record.url?scp=85055516178&partnerID=8YFLogxK

U2 - 10.1016/S2215-0366(18)30334-1

DO - 10.1016/S2215-0366(18)30334-1

M3 - Comment/debate

C2 - 30401440

AN - SCOPUS:85055516178

SN - 2215-0366

VL - 5

JO - The Lancet Psychiatry

JF - The Lancet Psychiatry

IS - 11

ER -